USC Norris launches global clinical trial testing potential therapy for aggressive type of breast cancer
USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has launched a global registration, phase 2 clinical trial investigating the efficacy of a potential new breast cancer therapy called ARX788.
The trial is … Read More »